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Abstract
Background: The National Institute for Health and Care Excellence’s Osteoarthritis (OA) guidelines recommended
that future research should consider the benefits of combination therapies in people with OA across multiple joint
sites. However, the clinical effectiveness of such approaches to OA management is unknown. This systematic review
therefore aimed to identify the clinical and cost effectiveness of multidisciplinary approaches targeting multiple
joint sites for OA in primary care.
Methods: A systematic review of randomised controlled trials. Computerised bibliographic databases were searched
(MEDLINE, EMBASE, CINAHL, PsychINFO, BNI, HBE, HMIC, AMED, Web of Science and Cochrane). Studies were included
if they met the following criteria; a randomised controlled trial (RCT), a primary care population with OA across at least
two different peripheral joint sites (multiple joint sites), and interventions undertaken by at least two different health
disciplines (multidisciplinary). The Cochrane ‘Risk of Bias’ tool and PEDro were used for quality assessment of eligible
studies. Clinical and cost effectiveness was determined by extracting and examining self-reported outcomes for pain,
function, quality of life (QoL) and health care utilisation. The date range for the search was from database inception
until August 2015.
Results: The search identified 1148 individual titles of which four were included in the review. A narrative review was
conducted due to the heterogeneity of the included trials. Each of the four trials used either educational or exercise
interventions facilitated by a range of different health disciplines. Moderate clinical benefits on pain, function and QoL
were reported across the studies. The beneficial effects of exercise generally decreased over time within all studies.
Two studies were able to show a reduction in healthcare utilisation due to a reduction in visits to a physiotherapist or a
reduction in x-rays and orthopaedic referrals. The intervention that showed the most promise used educational
interventions delivered by GPs with reinforcement by practice nurses.
Conclusions: There are currently very few studies that target multidisciplinary approaches suitable for OA across
multiple joint sites, in primary care. A more consistent approach to outcome measurement in future studies of this
nature should be considered to allow for better comparison.
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Background
Osteoarthritis (OA) is the most prevalent form of arth-
ritis and a chronic condition for which there are few ef-
fective treatments [1]. OA management has been the
focus of international guidelines and recommendations
over the last decade [2–7]. In the UK the National Insti-
tute for Health and Care Excellence (NICE) [7] has pro-
duced guidelines for OA, providing a range of effective
treatment recommendations for the peripheral joint sites
of the hands, hips, knees and feet.
It has been highlighted that people with OA generally
have more than one painful joint site. A UK population
survey identified that 68 % of people that self-report
joint pain do so in multiple sites (two or more sites from
the hands, hips, knees and feet), and 1.76 million people
in the UK have sought treatment for osteoarthritis in
two or more sites of the body [8, 9]. However, existing
guidelines have been derived from trials of OA examin-
ing therapies for single joint sites, and therefore the
NICE OA Guideline Development Group [7] suggested
that future research should consider combination ther-
apies for OA in multiple joint sites. The term ‘combin-
ation therapies’ suggests packages of care that cover a
wide range of interventions delivered by a wide range of
health disciplines; including multidisciplinary team ap-
proaches. The effectiveness of multidisciplinary packages
of care that have been shown to be suitable across mul-
tiple sites of OA in primary care is currently unknown.
An initial pilot search identified no studies that had tar-
geted multidisciplinary interventions for individuals with
multiple sites of OA. Therefore the aim of this systematic
review was to identify randomised controlled trials (RCTs)
of adults populations with OA across multiple joint sites,
receiving primary care based interventions involving
multidisciplinary packages of care that utilised the NICE
core treatments for OA [7] (access to information (educa-
tion), exercise, weight loss), compared to single discipline
interventions, no intervention or usual care.
Methods
The methodology used for this systematic review was in
line with those set out by the Centre for Reviews and
Dissemination (CRD) [10] Reporting of this systematic
review is guided by the Preferred Reporting Items for
Systematic Reviews and Meta-Analysis (PRISMA) check-
list [11]. A review protocol is available on request from
the corresponding author.
Searches
The search strategy was customised for use in databases
searchable through the UK National Health Service
(NHS) Evidence portal (MEDLINE 1946-, EMBASE 1974-
, CINAHL 1981-, PsychINFO 1806-, British Nursing Index
1985- (BNI), Health Business Elite 1922- (HBE), Health
Management Information Consortium 1983- (HMIC), Al-
lied and Complimentary Medicine 1985- (AMED)). The
Web of Science databases 1950- and the Cochrane Library
1995- were also searched. Search terms were combined
for the study design (RCTs); the condition (OA in two or
more sites from the hands, hips, knees or feet); profession
(primary care multidisciplinary health professionals) and
the setting (primary care settings). The full list of search
terms is available as an appendix (see Appendix).
The date range for the search was from the inception
of the databases until August 2015. Reference list checks
were undertaken of all the eligible papers identified
within review, current OA guidelines and systematic re-
views considering non-pharmacological interventions for
OA in primary care. Medical subject headings (MESH
terms) were utilised and ‘exploded’. Wild-card characters
ensured that all forms of searched words were included.
Eligibility criteria
Table 1 describes the inclusion and exclusion criteria for
this review.
Selection of eligible studies
The screening of titles was undertaken by the first re-
viewer (AF). If there was uncertainty regarding the eligi-
bility of a study title the abstract was obtained and
added into the next phase of the review (abstract screen-
ing phase) for further clarification.
Abstracts were then screened for eligibility by the first re-
viewer (AF) (Table 1.). Inclusion in the review was deter-
mined through the use of an abstract eligibility screening
tool designed by AF, KD and EH. The screening tool was
designed to simplify the screening process and ensure all ab-
stracts were assessed in a uniform manner to ensure all
those deemed eligible met the criteria laid down in the re-
view protocol. The screening tool allowed the reviewers to
screen abstracts for four key eligibility headings, i) RCT, ii)
Eligible participants, iii) Multidisciplinary interventions, iv)
Key outcomes. To test the reliability of the screening tool, it
was pilot tested by three reviewers for the first 20 abstracts
(AF, KD & EH). This allowed testing for appropriateness
and usability and checked the level of agreement amongst
the reviewers. A good level of agreement (19/20) between
the reviewers allowed the remaining abstracts to be screened
by the first reviewer (AF). Eligible abstracts were included in
the next stage of the review (the ‘full paper’ stage) if they
met all four criteria on the screening tool or if further clarifi-
cation on any of the criteria was needed.
For the ‘full paper’ stage a decision was made ‘a priori’ that
where there was uncertainty or disagreement on the eligibil-
ity of full papers between the first and second reviewer (AF,
KD); those papers would be taken forward to be reviewed
by all three reviewers (AF, KD, EH). This process yielded a
final set of papers for the data extraction phase.
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Data extraction
The clinical and cost effectiveness of the interventions was
determined through self-reported outcomes for pain, func-
tion, quality of life (QoL) and health care utilisation. A data
extraction tool was formulated by AF specifically for the re-
view and tailored to the review question. The extraction
tool was piloted by three reviewers (AF, KD & EH) and
amendments were agreed to make the tool more effective
at extracting only the data required. Data extraction was
undertaken independently by two reviewers (AF, KD) for all
papers that met the eligibility criteria for the review, with
the third reviewer (EH) extracting data from half of the eli-
gible papers, to again check the level of agreement.
Quality assessment/Risk of bias
The Cochrane ‘Risk of Bias’ tool [12] was utilised for qual-
ity assessment in the review (see Table 2). The Cochrane
risk of bias tool is the most comprehensive approach to
assessing the potential for bias in RCTs included in sys-
tematic reviews [12]. The Cochrane tool has six domains
for the assessment of risk of bias. The Physiotherapy Evi-
dence Database (PEDro) [13] was also used as it focusses
on trials delivered by therapists and provides a score from
eleven domains to grade each paper (Table 3).
Results
The searches identified 1148 titles, leaving 827 after de-
duplication. The screening of titles reduced the number of
papers from 827 to 211. The review of abstracts resulted
in the removal of 164 papers (132 involved ineligible par-
ticipants, 17 did not include a suitable multidisciplinary
intervention and 15 were not RCTs). Of the remaining 47
full papers, two were from the same study, five were not
available in English, 10 did not include eligible partici-
pants, 16 did not use a multidisciplinary intervention and
nine were not an RCT. This deductive process left five pa-
pers from three studies. Three papers were eligible for the
review; one protocol paper and one preliminary results
paper from two of the studies were retained for study in-
formation. Reference list checks of a relevant systematic
review [14] identified one additional study that was
deemed eligible. Figure 1 sets out the review process in a
flowchart. An overview of the four studies included in the
review and the key findings are presented in Table 4. A de-
tailed description of the interventions tested within the
four studies are presented in Table 5.
The risk of bias was unclear in a number of sections
of the eligible studies. The best way of appraising this
within studies was to judge the quality and consistency
of blinding, but the nature of the interventions meant
that single-blinding was the only option in three studies
and blinding went unreported in the cluster RCT. In using
the Cochrane risk of bias tool it is hoped that ‘other
sources of bias’ are identified through the use of the five
main domains. It was clear that clarity of reporting the
prevention of bias in clinical trials improved within the
most current studies. The reporting of such studies will
have been guided by the consolidated standards of report-
ing trials checklist (CONSORT) [15] which recommends
Table 2 Appraisal of the four reviewed studies using the Cochrane risk of bias tool
Hopman-Rock &
Westhoff (2000) [16]
van Baar et al.
(2001) [19]
Rosemann et al.
(2007) [18]
Hansson et al.
(2010) [17]
Sequence generation ? + + ?
Allocation concealment ? + + +
Blinding ? ? ? ?
Incomplete outcome data ? + ? +
Selective outcome reporting ? ? ? +
Other sources of bias ? ? ? ?
Key (Low risk of bias = +, High risk = −, Unclear of risk = ?)
Table 1 Criteria for including studies in the review
Inclusions
Population Adults aged 18 years and over with OA. The study
population must have OA in multiple joint sites (at least
two sites from the hand, hip, knee or foot).
Intervention Multidisciplinary interventions that target the NICE7 core
treatments in primary care (“multidisciplinary” is defined as
involving at least two different health disciplines).
Comparison Usual care, uni-disciplinary approaches, placebo interventions
or no intervention.
Outcome Primary outcomes of interest were self-reported pain,
function, QoL and health care utilisation.
Design The study population must form part of an RCT.
Exclusions
Population Inflammatory arthritis; surgical interventions, specified
peripheral joint pain conditions, chronic widespread pain
(CWP).
Intervention Non-randomised controlled trials.
Studies not published in the English language.
Comparison Surgical interventions.
Outcome No measure of any of the key outcomes listed in the
inclusion criteria
Design Single discipline approaches
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that the key items from the Cochrane Risk of Bias tool are
addressed in study publications.
A meta-analysis of the numerical data reported in the
four studies was unable to be conducted as the data were
considered too clinically diverse to synthesise. A narrative
review of the four studies, the outcomes utilised and the
results of the interventions was therefore conducted.
The overarching theme of the four papers was one of
supporting self-management of OA via varying multidis-
ciplinary approaches. The consistent interventions in
each of the four studies were education and exercise. In-
terventions were shown to have moderate effects on
QoL [16, 17], pain [16, 18, 19] and function (SOLEC
test) [17]. In terms of health care utilisation, one study
identified a reduction in orthopaedic referrals and x-rays
[18] and one study identified a decrease in physiotherapy
visits in their experimental group [16]. The clinical ef-
fects of exercise were shown to decline over time [19].
While each study used core interventions endorsed by
NICE suitable for multiple sites of OA in primary care, they
all had different aims and utilised different outcome mea-
sures, even when the outcomes were measuring the same
attribute, i.e. pain. Each study used different disciplines to
achieve a multidisciplinary approach and three of the four
studies focussed solely on the hip or knee as sites of OA.
Only one study targeted the hand alongside other sites [17].
No studies included the foot as a site suitable for their
interventions. Each study had a higher number of female
participants. The length of time participants had OA was
generally unclear as it was only reported by one study [16].
Pain
Pain was described as an outcome in three of the four
studies [16, 17, 19]. The study by van Baar and colleagues
[19] used a VAS of 0–100, reporting baseline pain scores
and mean change at three different follow-up points (12,
24, 36 weeks). The effect size for pain at 12 weeks was
0.58 dropping to 0.36 at 24 weeks and 0.20 at the 36 week
follow-up point; suggesting the benefits of their interven-
tion on pain severity reduced over time [19].
Similarly Hopman-Rock and Westhoff [16] used a VAS
of 0–100 to measure of pain intolerance and presented
pre-test, post-test and follow-up results [16]. Where van
Baar and colleagues identified a reduction in the improve-
ments of pain severity over time [19], Hopman-Rock and
Westhoff, demonstrated that a reduction of pain ‘post-test’
in their results had completely diminished at the 6 month
follow-up point with pain severity scores worse than that
at ‘pre-test’ level [16].
Rosemann and colleagues did not describe pain as a
specific outcome. However, they did use the AIMS2-SF
[20] within which pain is reported as ‘symptom’ [21].
Within the AIMS2-SF, there was no statistically signifi-
cant improvement in pain.
Table 3 Appraisal of the four studies using PEDro scores
Hopman-Rock & Westhoff
(2000) [16]
van Baar et al.
(2001) [19]
Rosemann et al.
(2007) [18]
Hansson et al.
(2010) [17]
1. Eligibility criteria were specified (1) (1) (1) (1)
2. Subjects were randomly allocated to groups 1 1 1 1
3. Allocation was concealed 0 1 0 1
4. The groups were similar at baseline regarding the
most important prognostic indicators
1 1 1 1
5. There was blinding of all subjects 0 0 0 0
6. There was blinding of all therapists who administered
the therapy
0 0 0 0
7. There was blinding of all assessors who measured
at least one outcome
0 0 1 0
8. Measures of at least one key outcome were obtained
from more than 85 % of the subjects initially allocated
to groups
1 1 0 1
9. All subjects for whom outcome measures were
available received the treatment or control condition
as allocated or, where this was not the case, data for
at least one key outcome was analysed by ‘intention
to treat’
1 1 1 1
10. The results of between-group statistical comparisons
are reported for at least one key outcome
1 1 1 1
11. The study provides both point measures and
measures of variability for at least one key outcome
1 1 1 1
12. Pedro Score 6 7 6 7
1 = yes; 0 = no or unsure (No.1 does not count towards the final score)
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Hansson and colleagues included pain dimensions from
the EQ5D [22] and ASES [23] as secondary outcome mea-
sures [17]. The pain and discomfort dimension of the
EQ5D significantly reduced following the intervention in
those who considered their pain and discomfort to be ex-
treme. There was no significant reduction in the pain di-
mension of the ASES which asked the participants
whether they were able to decrease their pain [17]. None
of the studies stated whether the improvements in pain
were joint specific (i.e. hip or knee etc.).
Function
Function was assessed in two studies using the IRGL [16,
19]. Reported as a measure of mobility in the Hopman-Rock
and Westhoff study [16], no significant difference (p= 0.18)
between the intervention and control group was identified.
Fig. 1 Flowchart documenting the study selection process for the review
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Table 4 An overview and key findings of the four studies included in the review
Studies & trial
design
Sample size Setting Health
disciplines
OA sites Mean age of
participants
(SD)
Primary
outcomes
within
studies
Secondary outcomes within
studies
Key findings of studies
Hopman-Rock &
Westhoff (2000)
[16]
RCT
N = 105
Intervention = 56
Control = 49
Single
Centre
(Netherlands)
Primary Care
Physiotherapy,
Occupational
Therapy (OT)
and General
Practitioner
Hip or Knee Intervention
=65.4 (5.3)
Control
=65.2 (5.7)
IRGL self-
reported
pain. Pain se-
verity (VAS)
QoL (VAS)
QoL seven question sum
score
Activity restriction, ROM
Muscle strength
Observed activity restrictions
Healthcare utilisation,
lifestyle behaviour, BMI
Significant MANOVA effects were found for
pain, QoL, quadriceps, BMI, physically active
lifestyle, and visits to the physical therapist.
Most effects were moderate at post-test as-
sessment and smaller at follow-up. No effects
were found for range of ROM or functional
tasks
van Baar et al.
(2001) [19]
Single blind RCT
N = 201
Intervention = 99
Control = 102
Multi-Centre
(Netherlands)
Primary Care
General
Practitioner
and
Physiotherapy
Hip or Knee Intervention
68.3 (8.4)
Control
=67.7 (9.2)
IRGL self-
reported dis-
ability, VAS
pain in the
past week
Observed disability, Drug
use NSAIDs/paracetamol,
Global perceived effect,
muscle strength & ROM hip,
knee, physical activity
At 24 weeks exercise treatment was
associated with a small to moderate effect
on pain during the past week (difference in
change between the two groups −11.5
(95 % CI −19.7 to −3.3). At 36 weeks no
differences were found between groups.
Rosemann et al.
(2007) [18]
3-arm pragmatic
cluster trial
N = 1021
Intervention 1
=345
Intervention 2
=344
Control = 332
Multi-Centre
(Germany)
Primary Care
General
Practitioner
and Practice
nurse
Hip or Knee Intervention
1 = 65.59
(14.68)
Intervention
2 = 66.27
(15.19)
Control
=66.11
(15.02)
AIMS2-SF
QoL, lower
body, upper
body,
symptom &
social.
IPAQ physical activity, BMI,
prescriptions. Health service
utilisation
Compared with the control group, for
intervention group II, significant changes in
the AIMS2-SF dimensions social (p < 0.001),
symptom (p = 0.048), and lower body (p =
0.049) were identified. Radiographs (P =
0.031) and orthopaedic referrals (p = 0.044)
decreased whereas prescriptions of pain re-
lievers increased significantly.
Hansson et al.
(2010) [17]
Single blind RCT
N = 114
Intervention = 61
Control = 53
Single
Centre
(Sweden)
Primary Care
Physiotherapy,
OT,
Orthopaedic
Specialist,
Nurse,
Nutritionist
Knee, Hip or Hand Intervention
=62 (9.43)
Control
=63 (9.51)
EQ5D index
and EQ5D
VAS
ASES pain, function & other
symptoms. GAT, SOLEO,
SOLEC, One legged jump/
raising, OA location & BMI
Significant differences between the
intervention group and the control group,
comparing the results at baseline and after
6 months in EuroQol-5D (p < 0.001) and in
SOLEC (p = 0.02) in favour of the intervention
group.
Key: AIMS2 Arthritis Impact Measurement Scale, ASES Arthritis Self-Efficacy Scale, BMI Body Mass Index, EQ-5D Euro QoL, European Quality of Life measure, GAT Grip Ability Test, IPAQ International Physical Activity
Questionnaire, GP General Practitioner, IRGL Impact of Rheumatic Disease on General Health and Lifestyle, NSAIDs Non-steroidal anti-inflammatory drugs, QoL Quality of Life, ROM Range of Movement, VAS Visual
Analogue Scale, SOLEO Stand On One Leg Eyes Open, SOLEC Stand On One Leg Eyes Closed
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Reported as a measure of disability van Baar and colleagues,
highlighted that their intervention had no effect at two
follow-up time points of 12 and 24 weeks [19]. Function
was also measured using a dimension of the ASES self-
efficacy assessment tool in the study by Hansson and col-
leagues, but no significant differences between the interven-
tion and control groups were found [17].
Quality of life
Two studies selected QoL as a primary outcome measure,
using the AIMS-2 SF [18] and the EQ5D [17]. In the clus-
ter RCT [18] the inclusion of a practice nurse intervention
(follow-up phone calls) alongside the GP intervention was
responsible for an improvement in QoL due to improving
‘symptoms’ (pain). Hansson and colleagues used the
Table 5 A detailed overview of the interventions included in the studies within the review
Studies Intervention(s) Control
Hopman-Rock & Westhoff
(2000) [16]
Six weekly sessions lasting 2 h.
First hour: Peer educator advice on Pathophysiology of OA, lifestyle
and physical activity, pain management, weight reduction and diet,
ergonomic and medical aspects of OA; treatments and x-rays. Ques-
tions answered by a visiting GP and OT.
Second Hour: Physiotherapy lead exercise program. Education on
rest and activity and the benefits of walking. Warming up exercises
and relaxation exercises specific to knee and hip. Fifteen minutes of
each session was spent on education about the balance between
rest and activity and the types of activity.
The course included the use of a pain diary and personal goal
planning.
Unclear - states without intervention
van Baar et al. (2001) [19] The patients were given exercise treatment individually by a
physiotherapist in primary care (1–3 sessions per week). In addition,
their GP provided patient education (including a brochure) and
medication management, if necessary.
One exercise protocol was used for both the hip and knee patients.
It included exercises for muscle function, mobility and coordination.
Instructions were also given for adaptation of the activities of daily
living and home exercises.
Treatment was restricted to that given by their GP
in the intervention, (patient education and
medication management, if necessary).
Rosemann et al. (2007) [18] Intervention 1: GPs received two interactive peer group meetings
(8 h each) that focussed on evidence based treatment of OA in
primary care (including a written summary of guidelines), arthritis
self-management programs and motivational skills for working with
patients. GPs were given patient education leaflets including a phys-
ical exercise programme in a booklet and on audio CD.
Intervention 2: GPs received the same as Intervention 1. in addition
a practice nurse was trained to monitor participants via a monthly
telephone call; and to check adherence to GP prescriptions and
advice and to ask about increasing pain and possible side effects of
medication
Usual care
Hansson et al. (2010) [17] The patient education programme for osteoarthritis (PEPOA). The
programme lasted for 5 weeks, with group sessions once a week,
3 h for each session.
Described as ‘living as usual’
First
session
A physiotherapist and occupational therapist provided
information about anatomy and physiology of pain and
coping with pain. Brainstorming was used to discover
what the participants found hard to do.
Second
session
A physiotherapist provided information about exercise
and physical activity and gave a practical demonstration
of home-training exercises for the lower extremity. A
demonstration of different kinds of orthopaedic aids for
the lower extremity was also given.
Third
session
An orthopaedic specialist, nurse and nutritionist provided
information about OA and current research. Information
about medications and appropriate diet were also given.
Fourth
session
An OT provided ergonomics and practical instructions
about equipment and technical aids. Feedback to the
brainstorming session from session one was provided.
Fifth
session
An OT provided information about surgery of the hand,
and demonstrated the use of orthopaedic aids for hands.
A practical demonstration of home training exercises for
the hand was provided.
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EQ5D to measure five dimensions of QoL. At baseline
16 % of participants reported the pain dimension of ex-
treme pain and discomfort; dropping to 13 % at the
6 month follow-up period. In comparison those reporting
extreme pain and discomfort in the control group in-
creased from 17 % at baseline to 21 % at the 6 month
follow-up [17]. The intervention group had a higher pro-
portion of participants improving after 6 months, yet this
was not shown to be statistically significant [17].
The IRGL was also reported in one study as a second-
ary outcome measure for QoL, using the dimension of
‘global perceived effect’ [19]. Initial improvements in glo-
bal perceived effect for the exercise group were shown
to reduce over time [19].
QoL was measured using a VAS in one study and was
found to be stable in a post-test assessment in the interven-
tion group and decreased slightly in the control group [16].
Health economics evaluation
None of the studies published a health economics evaluation
of the interventions tested, however two did assess ‘Health
Service Utilisation’ [16, 18]. Hopman-Rock and Westhoff
measured the use of health care resources in both interven-
tions used within their study. They found no differences in
the use of medication, the number of participants consulting
their GP with OA complaints, or in the mean number of
GP consultations. There was a reduction in those consulting
a physiotherapist at the 6 month follow-up point [16]. Rose-
mann and colleagues reported that there were significant re-
ductions in orthopaedic referrals and x-rays within the
intervention group that included a GP consultation and
practice nurse telephone follow-up [18]. A summary of the
key findings for each outcome can be seen in Table 6.
One observation by Hopman-Rock and Westhoff was
the need to consider proactive follow-up; which was the
aim of the study by Rosemann and colleagues [18]. The
most effective intervention of the four studies appeared to
be proactive nurse follow-up to GP consultations, where
training was delivered to the health professionals rather
than patients and significant improvements were seen in
self-efficacy along with a reduction of orthopaedic refer-
rals and x-rays and increased uptake of Paracetamol [18].
The findings of Rosemann and colleagues suggest the
interaction of both the GP and practice nurse offered a
continuing care approach above and beyond that of a GP
consultation alone and more effective than the self-
management programs utilised in the other studies.
Discussion
The four studies identified in the systematic review were
very clinically and methodologically diverse and a meta-
analysis was therefore not undertaken. Multidisciplinary ap-
proaches with education and exercise were the primary in-
terventions for self-management of OA and overall
moderate improvements were shown for pain, function,
QoL with reduced orthopaedic referrals and x-rays. The
review aimed to be inclusive in its approach to the eligi-
bility of studies. Two sites of OA were classed as ‘mul-
tiple sites’ and a minimum of two health disciplines was
considered multidisciplinary. Additional trial protocols
and trial development publications were identified in
the search [24, 25] from the four studies in the review
but there was limited evidence for effective multidiscip-
linary packages for implementing core OA recommen-
dations in primary care.
Clinical OA guidelines have emphasised that treat-
ments for OA are suitable for all peripheral joint sites
[3–7] so if core interventions could be successfully im-
plemented for multisite OA, this could have a significant
impact on OA pain and disability [26, 27]. Outcomes
often attributed to single site pain disorders are ex-
plained, at least in part, by multisite pain or pain else-
where [28, 29] and the disappointing results for the
management of OA in single sites may be explained by
other painful joint sites [30]. To evaluate the true impact
of an OA intervention the number of sites of OA should
be either reported or adjusted for in the analysis.
Our findings are comparable to those of Cuperus et al.
[31] where a multidisciplinary face-to-face treatment pro-
gram was compared to a telephone based treatment pro-
gram in secondary care for generalised osteoarthritis
(GOA). Results were generally inconclusive, with no differ-
ences observed between groups for the primary outcome.
A weakness of this review was the lack of eligible pri-
mary care studies of interventions in multiple joint sites
and the complexity of the interventions meant that the
‘exact ingredient’ of the intervention was often hard to
specify with issues in developing, describing, and repro-
ducing interventions not fully reported.
The Cochrane risk of bias check list and the PEDro
scale [12, 13] identified a number of ‘unclear’ categories
when rating the success of blinding rendering judgement
on the quality of the studies difficult. Findings would have
also been easier to synthesise with consistency in out-
comes measured. Two outcomes that could have been
standardised in each study were pain e.g. intensity, sever-
ity, site, frequency, or duration - yet only two of the four
studies considered pain to be a primary outcome [16, 19]
- and function e.g. Western Ontario and McMaster Uni-
versities Osteoarthritis Index (WOMAC) [32].
In summary the review was unable to determine the
clinical and cost effectiveness of multidisciplinary inter-
ventions in primary care for OA in multiple sites. The one
intervention that showed most promise was a GP consult-
ation delivering OA education and exercise advice with
telephone follow-up with practice nurses. Whether this
type of intervention can be successfully implemented in
primary care systems is yet to be determined.
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Conclusions
This systematic review identified four studies that used ei-
ther educational or exercise interventions via various multi-
disciplinary team approaches to improve clinical and cost
effectiveness outcomes suitable for OA across multiple joint
sites. However, a meta-analysis was unachievable due to the
heterogeneous nature of the studies.
A consistent approach to outcome measurement in future
studies of OA across multiple sites is needed as there is lim-
ited consensus on outcome measures at present, leading to
greater heterogeneity across studies. A narrative review
found that only one study was able to report significant im-
provements in outcomes that were sustainable over time.
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GOA, General Osteoarthritis; GP, General Practitioner;
HBE, Health Business Elite; HMIC, Health Management
Information Consortium; ICOAP, The Intermittent and
Constant Pain Score; IPAQ, International Physical Activity
Questionnaire; IRGL, Impact of Rheumatic Disease on
General Health and Lifestyle; MESH, medical subject
headings; NICE, National Institute for Health and Care
Excellence; NSAIDs, Non-steroidal anti-inflammatory
drugs; OA, osteoarthritis; OARSI, Osteoarthritis Research
Society International; OMERACT, Outcome Measures in
Rheumatology; QoL, quality of life; RCT, randomised con-
trolled trial; ROM, range of movement; SOLEC, stand on
one leg eyes closed; SOLEO, stand on one leg eyes open;
VAS, visual analogue scale; WOMAC, The Western On-
tario and McMaster Universities Arthritis Index
Table 6 Summary of key finds the main outcomes
Studies Pain Function Quality of Life (QoL) Health care utilisation
Hopman-Rock &
Westhoff (2000) [16]
The IRGL pain subscale
indicated that the
experimental group reported
fewer pain symptoms at the
post-test assessment than the
control group. Pain (VAS)
showed a positive effect of
the intervention on the ex-
perimental group
There was no improvement in
IRGL mobility. No significant
differences were found for
extension, flexion, exorotation
or endorotation of the hips
and knees. The strength of
knee extensors improved in
both legs in post-test assess-
ment. MANOVA showed a sta-
tistically significant
improvement in strength of
left knee extensor. No statisti-
cally significant improvements
were seen in the functional
tasks of walking, timed up-
and-go, stair climbing and toe
reaching as both groups
improved.
Whilst QoL (VAS) remained
stable at the post-test assess-
ment in the experimental
group, it had decreased in
the control group. At F/U this
was no longer found.
No statistically significant
differences were found in the
use of medication or on the
number of GP consultations.
Physical therapy consultations
were reduced
van Baar et al.
(2001) [19]
At 24 weeks (12 weeks after
completion of treatment), a
beneficial effect was seen for
pain during the past week.
Compared with the post-
treatment level (week 12) the
effect size had declined to
0.36, indicating a small to
moderate effect.
At 24 weeks no effects were
found for self-reported disabil-
ity, muscle strength, and
range of motion. Similar ef-
fects were found at week 36.
_ There was a reduction in the
use of paracetamol at
24 weeks that remained
stable at 36 weeks F/U
Rosemann et al.
(2007) [18]
Statistically significant
improvements were seen for
the ‘Symptom’ component of
the AIMS2-SF in intervention
group 2.
No statistically significant
improvements in IPAQ sores
Statistically significant
improvements were shown
for the lower body, symptom
and social components of
the AIMS2-SF
There was a statistically
significant reduction in
orthopaedic referrals in
intervention group 2 and x-rays
in intervention groups 1 & 2
Hansson et al.
(2010) [17]
No improvements were
shown for ASES pain scores.
EQ-5D scores reduced in the
experimental group.
There was no statistically
significant improvement in
ASES function, GAT or SOLEO
but there was a statistically
significant improvement on
SOLEC
There was a statistically
significant improvement in
the EQ-5D VAS but not the
EQ-5D index.
_
Key: AIMS2 Arthritis Impact Measurement Scale, ASES Arthritis Self-Efficacy Scale, EQ-5D Euro QoL, European Quality of Life measure, GAT Grip Ability Test, IPAQ
International Physical Activity Questionnaire, IRGL Impact of Rheumatic Disease on General Health and Lifestyle, VAS Visual Analogue Scale, SOLEO Stand On One
Leg Eyes Open; SOLEC Stand On One Leg Eyes Closed
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Table 7 Full search terms for each database. Full search terms provided for ten searched databases
Database Search Results
AMED exp RANDOMIZED CONTROLLED TRIALS/OR exp TREATMENT OUTCOME/OR exp
COMPARATIVE STUDY/OR exp "DELIVERY OF HEALTH CARE"/"controlled clinical trial".ti,ab
randomized.ab placebo.ab exp CLINICAL TRIALS/randomly.ab trial.ti,ab 1 OR 2 OR 3 OR 4
OR 5 OR 6 OR 7 exp ANIMALS/NOT humans.sh 8 not 9 exp OSTEOARTHRITIS/
osteoarthritis.ti,ab OA.ti,ab ((degenerative adj2 arthritis)).ti,ab((joint adj3 pain)).ti,ab((knee
adj3 pain)).ti,ab((hip adj3 pain)).ti,ab((hand adj3 pain)).ti,ab((foot adj3 pain)).ti,ab 11 OR 12
OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 10 AND 20 multidisciplinar*.ti,ab
interdisciplinar*.ti,ab multiprofessional*.ti,abAMEDmultimodal*.ti,ab exp PATIENT CARE
TEAM/"self-manage*".ti,ab exp PATIENT CARE MANAGEMENT/"patient education".ti,ab
((pain clinics OR pain service OR pain relief)).ti,ab exp OCCUPATIONAL THERAPY/
"occupational therap*".ti,ab"physiotherap*".ti,ab exp PHYSIOTHERAPY/OR exp PHYSICAL
THERAPY MODALITIES/exp TREATMENT OUTCOME/nurse*.ti,ab exp NURSING/
pharmac*.ti,ab exp PHARMACOLOGY/OR exp COMPLEMENTARY THERAPIES/"non
pharmacol*".ti,ab exp DIET THERAPY/Dietetic*.ti,ab exp OSTEOPATHY/osteopath*.ti,ab exp
CHIROPRACTIC/chiroprac*.ti,ab "clinical psychol*".ti,ab exp PODIATRY/podiat*.ti,ab 22 OR
23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36
OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 21
AND 50 exp FAMILY PRACTICE/exp PRIMARY HEALTH CARE/exp COMMUNITY HEALTH
SERVICES/"general pract*".ti,ab ((primary adj2 care)).ti,ab ((secondary adj2 care)).ti,ab "family
pract*".ti,ab "family physician*".ti,ab "family doctor*".ti,ab GP.ti,ab exp AMBULATORY CARE/
((ambulatory adj2 care)).ti,ab "community health service*".ti,ab "community health
care*".ti,ab "outpatients clinics".ti,ab 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR
60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 51 AND 67
36
BNI ((randomized controlled trial)).ti,ab ((randomised controlled trial)).ti,ab RCT.ti,ab
randomised.ti,ab randomized.ti,ab randomly.ab placebo.ab trial.ti,ab 1 OR 2 OR 3 OR 4
OR 5 OR 6 OR 7 OR 8 exp "ARTHRITIS AND RHEUMATISM"/OR exp JOINT DISORDERS/
exp "ARTHRITIS AND RHEUMATISM"/OR exp JOINT DISORDERS/osteoarthritis.ti,ab
OA.ti,ab ((degenerative arthritis)).ti,ab ((joint pain)).ti,ab ((knee pain)).ti,ab ((hip pain)).ti,ab
((hand pain)).ti,ab ((foot pain)).ti,ab 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17
OR 18 9 AND 19 exp MULTIDISCIPLINARY TEAMS/OR exp INTERPROFESSIONAL
RELATIONS/OR exp "CONTINUITY OF CARE"/interdisciplinary.ti,ab multiprofessional*.ti,ab
multimodal*.ti,ab ((Patient care team)).ti,ab ((self manage*)).ti,ab ((patient care
management)).ti,ab ((patient education)).ti,ab ((pain clinics)).ti,ab exp "PAIN AND PAIN
MANAGEMENT"/OR exp ALTERNATIVE THERAPIES/exp
OCCUPATIONAL THERAPY/((occupational therap*)).ti,ab exp PHYSIOTHERAPY/
physiotherap*.ti,ab ((treatment outcome)).ti,ab exp NURSE PATIENT RELATIONS/OR exp
NURSE SPECIALIST/OR exp NURSE PRACTITIONER/exp PHARMACISTS/exp
PHARMACISTS/pharmac*.ti,ab ((non pharmacol*)).ti,ab OBESITY/dietician*.ti,ab
dietetics.ti,ab osteopath.ti,ab osteop*.ti,ab chiropractice.ti,ab chiropractic*.ti,ab exp
"FOOT CARE AND DISORDERS"/podiatry.ti,ab podiat*.ti,ab 21 OR 22 OR 23 OR 24 OR 25
OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38
OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 20 AND 50
31
CINAHL RANDOMIZED CONTROLLED TRIALS/OR COCHRANE LIBRARY/OR exp CLINICAL TRIALS/
((controlled clinical trial)).ti,ab randomi?ed.ab placebo.ab random*.ab trial*.ti,ab 1 OR 2
OR 3 OR 4 OR 5 OR 6 ANIMALS/NOT humans.sh 7 not 8 OSTEOARTHRITIS, HIP/OR
OSTEOARTHRITIS, KNEE/OR OSTEOARTHRITIS, WRIST/OR exp OSTEOARTHRITIS/
osteoarthritis.ti,ab OA.ti,ab ((degenerative adj2 arthritis)).ti,ab ((joint adj3 pain)).ti,ab
((knee adj3 pain)).ti,ab ((hip adj3 pain)).ti,ab ((hand adj3 pain)).ti,ab ((foot adj3 pain)).ti,ab
10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 9 AND 19
multidisciplinar*.ti,ab exp MULTIDISCIPLINARY CARE TEAM/interdisciplinar*.ti,ab
multiprofessional*.ti,ab multimodal*.ti,ab exp PATIENT CARE/((patient education)).ti,ab
PAIN CLINICS/OR CHRONIC PAIN/((pain sevice OR pain relief)).ti,ab OCCUPATIONAL
THERAPY SERVICE/OR exp OCCUPATIONAL THERAPY/((occupational therap*)).ti,ab
PHYSIOTHERAPY EVIDENCE DATABASE/physiotherap*.ti,ab exp TREATMENT OUTCOMES/
nurs*.ti,ab nursing.ti,ab ((practice nurse)).ti,ab pharmac*.ti,ab PHARMACISTS/((non
pharmacol*)).ti,ab DIETETICS/dietic*.ti,ab OSTEOPATHS/OR OSTEOPATHIC MEDICINE/OR
MANIPULATION, OSTEOPATHIC/osteopath*.ti,ab chiroprac*.ti,ab CHIROPRACTORS/
PSYCHOLOGY, CLINICAL/((clinical psycholog*)).ti,ab PODIATRY/OR PODIATRY PRACTICE/
OR PODIATRIC CARE/OR PODIATRIC ASSESSMENT/OR RESEARCH, PODIATRY/
podiatr*.ti,ab 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR
32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR
45 OR 46 OR 47 OR 48 OR 49 OR 50 20 AND 51 FAMILY PRACTICE/OR MEDICAL
PRACTICE/PHYSICIANS, FAMILY/PRIMARY HEALTH CARE/exp COMMUNITY HEALTH
187
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SERVICES/((general pract*)).ti,ab ((primary adj2 care)).ti,ab ((secondary adj2 care)).ti,ab
((family pract*)).ti,ab ((family physician*)).ti,ab ((family doctor*)).ti,ab GP.ti,ab
AMBULATORY CARE/((ambulatory adj2 care)).ti,ab ((community health service*)).ti,ab
((community health care*)).ti,ab OUTPATIENTS/OR OUTPATIENT SERVICE/((outpatients
clinics)).ti,ab 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR
64 OR 65 OR 66 OR 67 OR 68 OR 69 52 AND 70
EMBASE ((randomi?ed controlled trial)).ti,ab RCT.ti,ab ((clinical trial*)).ti,ab random*.ab
placebo*.ab ((Multi center study)).ti,ab 1 OR 2 OR 3 OR 4 OR 5 OR 6 exp HIP
OSTEOARTHRITIS/OR exp KNEE OSTEOARTHRITIS/OR exp OSTEOARTHRITIS/
osteoarthritis.ti,ab OA.ti,ab ((degenerative adj2 arthritis)).ti,ab ((joint adj3 pain)).ti,ab
((knee adj3 pain)).ti,ab ((hip adj3 pain)).ti,ab ((foot adj3 pain)).ti,ab 8 OR 9 OR 10 OR 11
OR 12 OR 13 OR 14 OR 15 7 AND 16 multidisciplinar*.ti,ab interdisciplinar*.ti,ab exp
INTERDISCIPLINARY RESEARCH/
multiprofessional*.ti,ab multimodal*.ti,ab exp PATIENT CARE TEAM/((self-manage*)).ti,ab
((patient care management)).ti,ab ((patient education)).ti,ab exp PAIN CLINIC/((pain
service OR pain relief)).ti,ab exp OCCUPATIONAL THERAPY/((occupational therapy)).ti,ab
((occupational therapy)).ti,ab OT.ti,ab exp PHYSIOTHERAPY/Physiotherap*.ti,ab exp
TREATMENT OUTCOME/PRIMARY NURSING CARE/nurs*.ti,ab ((practice nurse)).ti,ab exp
"PHARMACY (SCIENCE)"/((community pharmac*)).ti,ab ((non pharmacol*)).ti,ab exp
DIETETICS/dietetic*.ti,ab exp OSTEOPATHIC PHYSICIANS/OR exp OSTEOPATHY/OR exp
OSTEOPATHIC PHYSICIAN/OR exp OSTEOPATH/osteopath*.ti,ab exp CHIROPODIST/OR
exp CHIROPODY/OR exp CHIROPRACTIC/OR exp CHIROPRACTIC PRACTICE/OR exp
CHIROPRACTOR/chiropract*.ti,ab exp CLINICAL PSYCHOLOGY/OR exp CLINICAL
PSYCHOLOGIST/((clinical psycholog*)).ti,ab exp PODIATRIST/OR exp PODIATRY/
podiat*.ti,ab 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR
29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR
42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 17 AND 51 exp GENERAL
PRACTICE/exp PRIMARY HEALTH CARE/exp COMMUNITY BASED REHABILITATION/OR
exp HEALTH CARE DELIVERY [+NT]/((community health services)).ti,ab ((primary adj2
care)).ti,ab ((secondary adj2 care)).ti,ab ((family pract*)).ti,ab ((family physician*)).ti,ab
((family doctor*)).ti,ab exp AMBULATORY CARE/((ambulatory adj2 care)).ti,ab
((community health service*)).ti,ab ((community health care*)).ti,ab exp OUTPATIENT
CARE/OR exp OUTPATIENT CLINIC/OR exp OUTPATIENT CLINICS, HOSPITAL/OR exp
OUTPATIENT DEPARTMENT/OR exp OUTPATIENT HEALTH CARE/OR exp OUTPATIENT
SERVICE/OR exp OUTPATIENT THERAPY/OR exp OUTPATIENT UNIT/53 OR 54 OR 55 OR
56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 52 AND 67
236
HEALTH
BUSINESS
ELITE
(randomi?ed controlled trial)).ti,ab ((controlled clinical trial)).ti,ab random*. placebo*.ab
((clinical trials as topic)).ti,ab trial.ti, 1 OR 2 OR 3 OR 4 OR 5 OR osteoarthritis.ti,ab
OA.ti,ab ((degenerative adj2 arthritis)).ti,ab ((joint adj3 pain)).ti,ab ((knee adj3 pain)).ti,ab
((hip adj3 pain)).ti,ab ((hand adj3 pain)).ti,ab ((foot adj3 pain)).ti,ab8 OR 9 OR 10 OR 11
OR 12 OR 13 OR 14 OR 15 ELITE7 AND 16multidisciplin*.ti,abinterdisciplin*.ti,ab
multiprofessional*.ti,ab multimodal.ti,ab ((patient care team)).ti, ((self manage*)).ti,ab
((patient care management)).ti,ab ((patient education)).ti,ab ((pain clinics OR pain
service OR pain relief)).ti,ab ((Occupational therapy)).ti,abPhysiother*.ti,ab ((Treatment
outcome)).ti, nursing.ti,ab ((practice nurse)).ti,ab Phamac*.ti,ab
((Nonpharmacol*)).ti,abDiet*.ti,ab osteopa*.ti,abchiroprac*.ti,ab ((Clinical psychol*)).ti,ab
podiat*.ti,ab18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR
29 OR 30 OR 31 OR 32 OR 33 OR 34 OR 35 OR 36 OR 37 OR 38 17 AND 39
38
HMIC Exp RANDOMISED CONTROLLED TRIALS/((controlled clinical trial)).ti,ab random*.ab
placebo.abHMICexp CLINICAL TRIALS/trial.ti,ab 1 OR 2 OR 3 OR 4 OR 5 OR 6HMICexp
OSTEOARTHRITIS/osteoarthritis.ti,ab OA.ti,ab ((joint adj3 pain)).ti,ab ((knee adj3
pain)).ti,ab ((hip adj3 pain)).ti,ab ((hand adj3 pain)).ti,ab ((foot adj3 pain)).ti,ab 8 OR 9 OR
10 OR 11 OR 12 OR 13 OR 14 OR 15 7 AND 16
39
MEDLINE exp RANDOMIZED CONTROLLED TRIAL/"controlled clinical trial".pt
randomized.abplacebo.ab exp CLINICAL TRIALS AS TOPIC/randomly.ab trial.ti,ab 1 OR 2
OR 3 OR 4 OR 5 OR 6 OR 7exp ANIMALS/NOT humans.sh 8 not 9 exp
OSTEOARTHRITIS/osteoarthritis.ti,ab OA.ti,ab ((degenerative adj2 arthritis)).ti,ab ((Joint
adj3 pain)).ti,ab ((knee adj3 pain)).ti,ab ((hip adj3 pain)).ti,ab ((hand adj3 pain)).ti,ab ((foot
adj3 pain)).ti,ab 11 OR 12 OR 13 OR 14 OR 15 OR 16 OR 17 OR 18 OR 19 10 AND 20
multidisciplinar*.ti,ab interdisciplinar*.ti,ab multiprofessional*.ti,ab multimodal*.ti,ab exp
PATIENT CARE TEAM/"self manage*".ti,ab exp PATIENT CARE MANAGEMENT/"patient
education".ti,ab exp PAIN CLINICS/((pain clinics OR pain service OR pain relief)).ti,ab exp
OCCUPATIONAL THERAPY/((occupational therap*)).ti,ab physiotherap*.ti,ab exp
PHYSICAL THERAPY MODALITIES/OR exp "PHYSICAL THERAPY (SPECIALTY)"/OR exp
"OUTCOME ASSESSMENT (HEALTH CARE)"/exp TREATMENT OUTCOME/nurse*.ti,ab exp
NURSING/pharmac*.ti,ab exp PHARMACY/"non pharmacol*".ti,abexp DIETETICS/
dietetician*.ti,ab exp OSTEOPATHIC PHYSICIANS/osteopath*.ti,abexp CHIROPRACTIC/
251
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chiroprac*.ti,ab exp PSYCHOLOGY, CLINICAL/"clinical psycholog*".ti,ab exp PODIATRY/
podiat*.ti,ab 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR
33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR
46 OR 47 OR 48 OR 49 OR 50 OR 51 21 AND 52 exp FAMILY PRACTICE/exp
PHYSICIANS, FAMILY/exp PRIMARY HEALTH CARE/exp COMMUNITY HEALTH SERVICES/
"general pract*".ti,ab ((primary adj2 care*)).ti,ab ((secondary adj2 care*)).ti,ab"family
pract*".ti,ab"family physician*".ti,ab "family doctor*".ti,ab GP.ti,ab exp AMBULATORY
CARE/((ambulatory adj2 care*)).ti,ab "community health service*".ti,ab "community
health care*".ti,ab exp OUTPATIENT CLINICS, HOSPITAL/OR exp OUTPATIENTS/54 OR 55
OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 OR 67 OR
6853 AND 70
PsycINFO (randomi?ed controlled trial)).ti,ab ((controlled clinical trial)).ti,ab random*.ab placebo.ab
exp CLINICAL TRIALS/trial.ti,ab 1 OR 2 OR 3 OR 4 OR 5 OR 6 exp CHRONIC PAIN/
osteoarthritis.ti,ab OA.ti,ab ((degenerative adj2 arthritis)).ti,ab ((joint adj3 pain)).ti,ab
((knee adj3 pain)).ti,ab ((hip adj3 pain)).ti,ab ((hand adj3 pain)).ti,ab ((foot adj3 pain)).ti,ab
8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 OR 15 OR 16 7 AND 17 multidisciplinar*.ti,ab
exp INTERDISCIPLINARY TREATMENT APPROACH/OR exp TREATMENT OUTCOMES/
interdisciplinar*.ti,ab multiprofessional*.ti,ab multimodal*.ti,ab ((patient care team)).ti,ab
((self manage*)).ti,ab ((patient care management)).ti,ab ((patient education)).ti,ab ((pain
clinics OR pain services OR pain relief)).ti,ab exp OCCUPATIONAL THERAPY/
((occupational therap*)).ti,ab (physiotherapy).ti,ab physiotherap*.ti,ab exp PHYSICAL
THERAPY/exp TREATMENT OUTCOMES/exp NURSING/((practice nurs*)).ti,ab
pharmac*.ti,ab exp PHARMACISTS/OR exp PHARMACOLOGY/OR exp DRUG THERAPY/
non-pharmacol*.ti,ab dietician*.ti,ab dietetics.ti,ab osteopath*.ti,ab chiroprac*.ti,ab
((Clinical psychology)).ti,ab exp CLINICAL PSYCHOLOGY/podiat*.ti,ab 19 OR 20 OR 21
OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34
OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 18
AND 47 exp FAMILY PHYSICIANS/exp PRIMARY HEALTH CARE/((primary adj2 care)).ti,ab
((secondary adj2 care)).ti,ab ((general prac*)).ti,ab ((family pract*)).ti,ab ((family
doctor*)).ti,ab GP.ti,ab exp OUTPATIENT TREATMENT/((ambulatory care)).ti,ab
((community health services)).ti,ab ((community health care)).ti,ab 49 OR 50 OR 51 OR
52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 48 AND 61
38
Cochrane MeSH descriptor Osteoarthritis explode all trees
osteoarthritis
(#1 OR #2)
MeSH descriptor Pain Clinics explode tree 1
multidisciplinary
interdisciplinary
MeSH descriptor Patient Care Team explode all trees
multiprofessional
multi modal
(#4 OR #5 OR #6 OR #7 OR #8 OR #9)
(#3 AND #10)
14 Cochrane trials
Web of
Science/BIOSIS
Topic = ((randomi?ed controlled trial or RCT or clinical trial)) AND Topic = ((osteoarthritis
or OA or genrali?ed arthritis or degenerative arthritis or multi-site osteoarthritis)) AND
Topic = ((outpatients or multidisciplinary or interdisciplinary or multiprofessional or
patient care management))
278
Totals Total of papers from all databases 1148
Totals Total of papers remaining after de-duplication (exact match) 1030
Totals Total of papers remaining after de-duplication (close match) 827
Totals Total of papers remaining after ‘Title Screen’ 211
Totals Total of papers remaining after ‘Abstract Screen’ 47
Totals Total of papers remaining after ‘Full text Screen’ 4
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